185737-62-6 Usage
Molecular structure
1H-Indole-3-acetic acid, 1-[(4-bromophenyl)methyl]-5-methoxy-2-methyl-, methyl ester is a chemical compound that contains a combination of 1H-indole-3-acetic acid and 1-[(4-bromophenyl)methyl]-5-methoxy-2-methyl groups. It is a methyl ester, which means it is formed by the esterification of the carboxyl group of 1H-indole-3-acetic acid with methanol.
Functional groups
The compound contains several functional groups, including an indole ring, a phenyl ring, a methyl ester group, a methoxy group, and a methyl group.
Synthetic applications
1H-Indole-3-acetic acid, 1-[(4-bromophenyl)methyl]-5-methoxy-2-methyl-, methyl ester is often used as a precursor in the synthesis of other chemical compounds, particularly in the fields of research and pharmaceuticals.
Biological activity
The compound may have potential biological activities due to the presence of indole-3-acetic acid, which is a plant hormone known for its role in plant growth and development.
Pharmacological properties
The presence of the bromophenyl group in the compound may contribute to its pharmacological properties, making it a potentially useful compound in the development of new drugs.
Interdisciplinary applications
This chemical compound has potential applications in various fields, including chemistry, biology, and pharmaceuticals, due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 185737-62-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,7,3 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 185737-62:
(8*1)+(7*8)+(6*5)+(5*7)+(4*3)+(3*7)+(2*6)+(1*2)=176
176 % 10 = 6
So 185737-62-6 is a valid CAS Registry Number.
185737-62-6Relevant articles and documents
Heterocyclic compounds as COX-2 inhibitors
-
, (2008/06/13)
The present invention relates to COX-2 inhibitors of the formula: STR1 wherein, A=halogen, C1 -C6 alkyl, SR1 or OR1 ; B=O, or H,H; X=Br or Cl; L=5-,6- or 7-membered heteroatom containing rings and is preferrably a 5-membered heteroaromatics such as thiazole, oxazole, imidazole, or oxadiazole; n=1-6, wherein the (C) is optionally branched; R=optionally substituted aryl wherein aryl is selected from phenyl, pyridyl, naphthyl, benzothienyl, or quinoxolyl, alkyl, carboxyl, esters, amino, amide, or urea; and R1 =alkyl. The compounds are useful as research tools and could be useful as potential therapeutic agents in the inhibition of the PGHS-2 isozyme and in the treatment of inflammation in mammals including humans or other conditions associated with the production of prostaglandins.
